FindTrial
Sign In

EFFICACY AND SAFETY OF OLMESARTAN IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION

EFFICACY AND SAFETY OF OLMESARTAN IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-001616-31-IT
Enrollment
Unknown
Registered
2004-09-28
Start date
2005-05-27
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients of both sexes, aged 65-89 years and with mild-moderate essential arterial hypertension MedDRA version: 6.1 Level: PT Classification code 10020823

Interventions

Trade Name: votum Product Name: NA Product Code: NA Pharmaceutical Form: Tablet INN or Proposed INN: olmesartan medoxomil CAS Number: 144689-63-4 Current Sponsor code: Cs-866 Concentration unit: mg mi

Sponsors

LUSOFARMACO
Lead Sponsor
GUIDOTTI
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026